Brief: Biodexa Receives Orphan Drug Designation In Europe For eRapa In FAP

Biodexa Pharmaceuticals

12/05/2025 13:38

May 12 (Reuters) - Biodexa Pharmaceuticals PLC 5MP1y.F:

BIODEXA RECEIVES ORPHAN DRUG DESIGNATION IN EUROPE FOR ERAPA IN FAP

Source text: ID:nGNX9d16Wf

Further company coverage: [5MP1y.F]